Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Mapa de calor
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
B
BBP
Virtus LifeSci Biotech Products ETF
86.2
6
USD
-1.23%
Setor:
Finanças
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
-1.23%
Mudança mensal
+2.41%
Mudança em 6 meses
+9.58%
Mudança anual
+53.38%
Fechamento anterior
87.3
3
Open
86.2
6
Mínimo
86.2
6
High
86.2
6
Volume
1
Mercados
US ETFs
BBP
Abrir gráfico completo
Full chart
Visão geral
Todos os ativos
Mapa de calor
Principais ativos
Market Value
Shares
Weight %
DREYFUS GOVERNMENT CASH MANAGE
1.87 M
1.87 M
4.17%
IBRX
ImmunityBio Inc
1.81 M
289.58 K
4.03%
MIRM
Mirum Pharmaceuticals Inc
1.09 M
10.51 K
2.42%
MRNA
Moderna Inc
1.02 M
23.20 K
2.28%
Dynavax Technologies Corp
979.86 K
63.28 K
2.18%
F
FOLD
Amicus Therapeutics Inc
925.66 K
64.78 K
2.06%
NVAX
Novavax Inc
920.05 K
104.02 K
2.05%
D
DAWN
Day One Biopharmaceuticals Inc
912.30 K
81.75 K
2.03%
AXSM
Axsome Therapeutics Inc
849.58 K
4 611.00
1.89%
ARDX
Ardelyx Inc
846.27 K
110.05 K
1.89%
BNTX
BioNTech SE
819.80 K
7 207.00
1.83%
GILD
GILEAD SCIENCES INC
805.57 K
5 675.00
1.80%
IOVA
Iovance Biotherapeutics Inc
792.13 K
310.64 K
1.77%
HALO
HALOZYME THERAPEUTICS INC
787.66 K
10.98 K
1.76%
KRYS
Krystal Biotech Inc
779.64 K
2 792.00
1.74%
AMGN
Amgen Inc
735.04 K
2 150.00
1.64%
ONC
BeOne Medicines Ltd
728.75 K
2 141.00
1.62%
BMRN
BIOMARIN PHARMACEUTICAL INC
724.73 K
12.82 K
1.62%
KNSA
Kiniksa Pharmaceuticals Intern
721.69 K
16.43 K
1.61%
INCY
INCYTE CORP
716.70 K
7 162.00
1.60%
1
2
3
4
Notícias
First Quarter Earnings: Sharpening Sector Divergence
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Medical Technology Stocks: Innovation Endures As Valuations Reset
AI And The Future Of Healthcare
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Can Forgotten Biotech Break Out?
Concerns Shift From Obsolescence To Oil
CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies
ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check - ImmunityBio (NASDAQ:IBRX)